<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2025, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Tue, 28 Oct 2025 16:07:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  S-8 POS    Adaptimmune Therapeutics             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-8+POS++++Adaptimmune+Therapeutics+++++++++++++/25513478.html</link>
   <description>si-local-file:///var/storage/secattach/20251028/25513478.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-8+POS++++Adaptimmune+Therapeutics+++++++++++++/25513478.html</guid>
   <pubDate>Tue, 28 Oct 2025 16:07:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19718971</category>
   	  </item>
  <item>
   <title>Form  S-8 POS    Adaptimmune Therapeutics             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-8+POS++++Adaptimmune+Therapeutics+++++++++++++/25513478.html</link>
   <description>si-local-file:///var/storage/secattach/20251028/25513478.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-8+POS++++Adaptimmune+Therapeutics+++++++++++++/25513478.html</guid>
   <pubDate>Tue, 28 Oct 2025 16:07:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19718971</category>
   	  </item>
  <item>
   <title>Form  S-8 POS    Adaptimmune Therapeutics             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-8+POS++++Adaptimmune+Therapeutics+++++++++++++/25513493.html</link>
   <description>si-local-file:///var/storage/secattach/20251028/25513493.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-8+POS++++Adaptimmune+Therapeutics+++++++++++++/25513493.html</guid>
   <pubDate>Tue, 28 Oct 2025 16:07:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19718971</category>
   	  </item>
  <item>
   <title>Form  S-8 POS    Adaptimmune Therapeutics             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-8+POS++++Adaptimmune+Therapeutics+++++++++++++/25513493.html</link>
   <description>si-local-file:///var/storage/secattach/20251028/25513493.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-8+POS++++Adaptimmune+Therapeutics+++++++++++++/25513493.html</guid>
   <pubDate>Tue, 28 Oct 2025 16:07:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19718971</category>
   	  </item>
  <item>
   <title>Form  S-8 POS    Adaptimmune Therapeutics             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-8+POS++++Adaptimmune+Therapeutics+++++++++++++/25513463.html</link>
   <description>si-local-file:///var/storage/secattach/20251028/25513463.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-8+POS++++Adaptimmune+Therapeutics+++++++++++++/25513463.html</guid>
   <pubDate>Tue, 28 Oct 2025 16:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19718971</category>
   	  </item>
  <item>
   <title>Form  S-8 POS    Adaptimmune Therapeutics             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-8+POS++++Adaptimmune+Therapeutics+++++++++++++/25513463.html</link>
   <description>si-local-file:///var/storage/secattach/20251028/25513463.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-8+POS++++Adaptimmune+Therapeutics+++++++++++++/25513463.html</guid>
   <pubDate>Tue, 28 Oct 2025 16:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19718971</category>
   	  </item>
  <item>
   <title>Form  POS AM     Adaptimmune Therapeutics             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++POS+AM+++++Adaptimmune+Therapeutics+++++++++++++/25513421.html</link>
   <description>si-local-file:///var/storage/secattach/20251028/25513421.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++POS+AM+++++Adaptimmune+Therapeutics+++++++++++++/25513421.html</guid>
   <pubDate>Tue, 28 Oct 2025 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19718971</category>
   	  </item>
  <item>
   <title>Form  POS AM     Adaptimmune Therapeutics             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++POS+AM+++++Adaptimmune+Therapeutics+++++++++++++/25513421.html</link>
   <description>si-local-file:///var/storage/secattach/20251028/25513421.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++POS+AM+++++Adaptimmune+Therapeutics+++++++++++++/25513421.html</guid>
   <pubDate>Tue, 28 Oct 2025 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19718971</category>
   	  </item>
  <item>
   <title>Form  25         Adaptimmune Therapeutics             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++25+++++++++Adaptimmune+Therapeutics+++++++++++++/25508817.html</link>
   <description>si-local-file:///var/storage/secattach/20251028/25508817.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++25+++++++++Adaptimmune+Therapeutics+++++++++++++/25508817.html</guid>
   <pubDate>Tue, 28 Oct 2025 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19718971</category>
   	  </item>
  <item>
   <title>Form  25         Adaptimmune Therapeutics             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++25+++++++++Adaptimmune+Therapeutics+++++++++++++/25508817.html</link>
   <description>si-local-file:///var/storage/secattach/20251028/25508817.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++25+++++++++Adaptimmune+Therapeutics+++++++++++++/25508817.html</guid>
   <pubDate>Tue, 28 Oct 2025 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19718971</category>
   	  </item>
  <item>
   <title>Form  8-K        Adaptimmune Therapeutics  For: Oct 15</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Adaptimmune+Therapeutics++For%3A+Oct+15/25473964.html</link>
   <description>si-local-file:///var/storage/secattach/20251020/25473964.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Adaptimmune+Therapeutics++For%3A+Oct+15/25473964.html</guid>
   <pubDate>Mon, 20 Oct 2025 07:50:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19718971</category>
   	  </item>
  <item>
   <title>Form  8-K        Adaptimmune Therapeutics  For: Oct 15</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Adaptimmune+Therapeutics++For%3A+Oct+15/25473964.html</link>
   <description>si-local-file:///var/storage/secattach/20251020/25473964.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Adaptimmune+Therapeutics++For%3A+Oct+15/25473964.html</guid>
   <pubDate>Mon, 20 Oct 2025 07:50:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19718971</category>
   	  </item>
  <item>
   <title>Adaptimmune to delist from NASDAQ following asset sale to US WorldMeds</title>
   <link>http://www.streetinsider.com/Corporate+News/Adaptimmune+to+delist+from+NASDAQ+following+asset+sale+to+US+WorldMeds/25473937.html</link>
   <description>&lt;p&gt;Adaptimmune Therapeutics plc (NASDAQ: ADAP) announced its board of directors has decided to voluntarily delist its American Depositary Shares from The Nasdaq Capital Market and deregister under the Securities Exchange Act of 1934.&lt;/p&gt;&lt;p&gt;The company notified Nasdaq on October 16, 2025, that it intends to file a Form 25 with the Securities and Exchange Commission on or about October 28, 2025. Trading of Adaptimmune's ADSs on Nasdaq is expected to be suspended following the market close on or about October 27, 2025.&lt;/p&gt;&lt;p&gt;The decision follows a transaction completed July 31, 2025, in which US WorldMeds acquired Adaptimmune's approved cell therapy TECELRA and</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Adaptimmune+to+delist+from+NASDAQ+following+asset+sale+to+US+WorldMeds/25473937.html</guid>
   <pubDate>Mon, 20 Oct 2025 07:42:41 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADAP</category>
   	  </item>
  <item>
   <title>Adaptimmune Therapeutics (ADAP) Halted, News Pending</title>
   <link>http://www.streetinsider.com/Trading+Halts/Adaptimmune+Therapeutics+%28ADAP%29+Halted%2C+News+Pending/25473931.html</link>
   <description>&lt;p&gt;Adaptimmune Therapeutics (NASDAQ: ADAP) Halted, News Pending&lt;br /&gt; &lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Trading+Halts/Adaptimmune+Therapeutics+%28ADAP%29+Halted%2C+News+Pending/25473931.html</guid>
   <pubDate>Mon, 20 Oct 2025 07:40:59 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADAP</category>
   	  </item>
  <item>
   <title>Adaptimmune Announces Delisting from Nasdaq</title>
   <link>http://www.streetinsider.com/Press+Releases/Adaptimmune+Announces+Delisting+from+Nasdaq/25473935.html</link>
   <description>&lt;p&gt;Philadelphia, Pennsylvania and Oxford, United Kingdom--(Newsfile Corp. - October 20, 2025) - Adaptimmune Therapeutics plc (NASDAQ: ADAP) (&quot;Adaptimmune&quot; or the &quot;Company&quot;) today announced that the Company's Board of Directors (the &quot;Board&quot;) has determined to initiate the delisting of its American Depositary Shares (&quot;ADSs&quot;), each representing six ordinary shares, from The Nasdaq Capital Market (&quot;Nasdaq&quot;) and deregistration under Section 12(b) of the Securities Exchange Act of 1934, as amended (the &quot;Exchange Act&quot;). &lt;/p&gt;&lt;p&gt;&lt;b&gt;Adrian Rawcliffe, Adaptimmune's Chief Executive Officer:&lt;/b&gt; &quot;As we noted previously, the transaction with USWM CT, LLC, a subsidiary of US WorldMeds Partners, LLC (collectively, &quot;US WorldMeds&quot;) followed an extensive</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Adaptimmune+Announces+Delisting+from+Nasdaq/25473935.html</guid>
   <pubDate>Mon, 20 Oct 2025 07:40:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADAP</category>
   	  </item>
  <item>
   <title>Adaptimmune Announces Delisting from Nasdaq</title>
   <link>http://www.streetinsider.com/Newsfile/Adaptimmune+Announces+Delisting+from+Nasdaq/25473935.html</link>
   <description>&lt;p&gt;Philadelphia, Pennsylvania and Oxford, United Kingdom--(Newsfile Corp. - October 20, 2025) - Adaptimmune Therapeutics plc (NASDAQ: ADAP) (&quot;Adaptimmune&quot; or the &quot;Company&quot;) today announced that the Company's Board of Directors (the &quot;Board&quot;) has determined to initiate the delisting of its American Depositary Shares (&quot;ADSs&quot;), each representing six ordinary shares, from The Nasdaq Capital Market (&quot;Nasdaq&quot;) and deregistration under Section 12(b) of the Securities Exchange Act of 1934, as amended (the &quot;Exchange Act&quot;). &lt;/p&gt;&lt;p&gt;&lt;b&gt;Adrian Rawcliffe, Adaptimmune's Chief Executive Officer:&lt;/b&gt; &quot;As we noted previously, the transaction with USWM CT, LLC, a subsidiary of US WorldMeds Partners, LLC (collectively, &quot;US WorldMeds&quot;) followed an extensive</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Newsfile/Adaptimmune+Announces+Delisting+from+Nasdaq/25473935.html</guid>
   <pubDate>Mon, 20 Oct 2025 07:40:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADAP</category>
   	  </item>
  <item>
   <title>Form  3          Adaptimmune Therapeutics  For: Sep 10  Filed by: Hill Christopher James</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Adaptimmune+Therapeutics++For%3A+Sep+10++Filed+by%3A+Hill+Christopher+James/25436527.html</link>
   <description>si-local-file:///var/storage/secattach/20251008/25436527.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Adaptimmune+Therapeutics++For%3A+Sep+10++Filed+by%3A+Hill+Christopher+James/25436527.html</guid>
   <pubDate>Wed, 08 Oct 2025 21:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19718971</category>
   	  </item>
  <item>
   <title>Form  3          Adaptimmune Therapeutics  For: Sep 10  Filed by: Hill Christopher James</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Adaptimmune+Therapeutics++For%3A+Sep+10++Filed+by%3A+Hill+Christopher+James/25436527.html</link>
   <description>si-local-file:///var/storage/secattach/20251008/25436527.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Adaptimmune+Therapeutics++For%3A+Sep+10++Filed+by%3A+Hill+Christopher+James/25436527.html</guid>
   <pubDate>Wed, 08 Oct 2025 21:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19718971</category>
   	  </item>
  <item>
   <title>Form  8-K        Adaptimmune Therapeutics  For: Sep 22</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Adaptimmune+Therapeutics++For%3A+Sep+22/25385053.html</link>
   <description>si-local-file:///var/storage/secattach/20250926/25385053.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Adaptimmune+Therapeutics++For%3A+Sep+22/25385053.html</guid>
   <pubDate>Fri, 26 Sep 2025 16:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19718971</category>
   	  </item>
  <item>
   <title>Form  8-K        Adaptimmune Therapeutics  For: Sep 22</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Adaptimmune+Therapeutics++For%3A+Sep+22/25385053.html</link>
   <description>si-local-file:///var/storage/secattach/20250926/25385053.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Adaptimmune+Therapeutics++For%3A+Sep+22/25385053.html</guid>
   <pubDate>Fri, 26 Sep 2025 16:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19718971</category>
   	  </item>
  <item>
   <title>Form  8-K        Adaptimmune Therapeutics  For: Sep 11</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Adaptimmune+Therapeutics++For%3A+Sep+11/25329806.html</link>
   <description>si-local-file:///var/storage/secattach/20250912/25329806.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Adaptimmune+Therapeutics++For%3A+Sep+11/25329806.html</guid>
   <pubDate>Fri, 12 Sep 2025 16:28:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19718971</category>
   	  </item>
  <item>
   <title>Form  8-K        Adaptimmune Therapeutics  For: Sep 11</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Adaptimmune+Therapeutics++For%3A+Sep+11/25329806.html</link>
   <description>si-local-file:///var/storage/secattach/20250912/25329806.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Adaptimmune+Therapeutics++For%3A+Sep+11/25329806.html</guid>
   <pubDate>Fri, 12 Sep 2025 16:28:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19718971</category>
   	  </item>
  <item>
   <title>Form  8-K        Adaptimmune Therapeutics  For: Sep 06</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Adaptimmune+Therapeutics++For%3A+Sep+06/25308953.html</link>
   <description>si-local-file:///var/storage/secattach/20250908/25308953.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Adaptimmune+Therapeutics++For%3A+Sep+06/25308953.html</guid>
   <pubDate>Mon, 08 Sep 2025 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19718971</category>
   	  </item>
  <item>
   <title>Form  8-K        Adaptimmune Therapeutics  For: Sep 06</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Adaptimmune+Therapeutics++For%3A+Sep+06/25308953.html</link>
   <description>si-local-file:///var/storage/secattach/20250908/25308953.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Adaptimmune+Therapeutics++For%3A+Sep+06/25308953.html</guid>
   <pubDate>Mon, 08 Sep 2025 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19718971</category>
   	  </item>
  <item>
   <title>Form  4          Adaptimmune Therapeutics  For: Sep 02  Filed by: Wood Gavin</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Adaptimmune+Therapeutics++For%3A+Sep+02++Filed+by%3A+Wood+Gavin/25293089.html</link>
   <description>si-local-file:///var/storage/secattach/20250903/25293089.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Adaptimmune+Therapeutics++For%3A+Sep+02++Filed+by%3A+Wood+Gavin/25293089.html</guid>
   <pubDate>Wed, 03 Sep 2025 17:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.19718971</category>
   	  </item>
 </channel>
</rss>
